Gyroscope Therapeutics Limited
Research and experimental development on biotechnology · London
Members Voluntary Liquidation (MVL, solvent)United KingdomIncorporated 2016Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
10131257- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2016-04-18
- Jurisdiction
- —
- Registered office
- 1, MORE LONDON PLACE, LONDON, SE1 2AF
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsA shared scalable suspension platform for cost effective manufacture of novel AAV gene therapiesLeadInnovate UK · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants£372,832awarded
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapiesLead
Innovate UK · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants
£372,832
awarded
Gyroscope Therapeutics Limitedlead£372,832
NHS Blood and Transplant£221,652
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapiesLeadISCF · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants£1,128,364whole project
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapiesLead
ISCF · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants
£1,128,364
whole project
Gyroscope Therapeutics LimitedleadCentre For Process Innovation LimitedFreeline Therapeutics LimitedNHS Blood And Transplant
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapiesISCF · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants£1,128,364whole project
A shared scalable suspension platform for cost effective manufacture of novel AAV gene therapies
ISCF · Collaborative R&D · 2018-11-01 – 2021-01-31 · with 3 other participants
£1,128,364
whole project
Gyroscope Therapeutics LimitedleadCentre For Process Innovation LimitedFreeline Therapeutics LimitedNHS Blood And Transplant